Get this delivered to your inbox, and more info about our products and services.
Why pharma stocks are shrugging off RFK’s new Covid vaccine restrictions
Investors didn't see the change as a major sell-the-news event.
14 words~1 min read
Related reading
European pharma secured a U.S. tariff win. Investors remain wary
Markets failed to rally despite what analysts said was a clear win for the European pharmaceutical sector in a trade update…
Abbott jumps on RFK Jr. health push — plus, reviews of Eli Lilly's obesity drug…
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
A health-care stock that's maintaining momentum despite regulatory headwinds
Frank Holland breaks down what traders are watching ahead of the new session.
Meta shares fall on AI restructuring report, while Lilly shrugs off Novo's…
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
We're dipping into our large cash pile to buy more of this health-care stock
The stock's drop this week isn't tied to fundamentals.
I talked to many health CEOs out West and see big things for drug stocks
Health care is going to resume its rightful place in big-time managers' portfolios.